This document summarizes a report by Medicus AI on the challenges facing diagnostic testing in 2021 based on surveys of healthcare professionals and patients. It found that digital solutions, telehealth services, common diagnostic records, prevention and screening, and decentralized medical biology are key challenges and opportunities. Focus areas for 2021 include patients demanding better health understanding, convenience and quality becoming central to care, homes extending healthcare services, and improved health record interoperability. Medicus AI is a digital health company that supports the diagnostic industry with integrated platforms to help users understand health data.

1. Tomorrow’s Lab Today:
Understanding the
challenges facing
diagnostic testing in 2021
through the lens of
COVID-19
Based on in-depth reporting taken from surveys
with healthcare professionals and patients and
interviews with biologists

2. This report has been developed by
Medicus AI, a leading technology
company supporting the diagnostic
testing partners with an innovative
digital health solution.
We embarked on this study to better
assess and understand the challenges
facing medical biologists and the
healthcare industry, and to identify
solutions to support a new era of
healthcare.
The research included over 2,200 survey
participants, and almost 20 expert
interviews, and was completed in
December 2020.
About this report

3. Confronting
new challenges
in diagnostic
testing

4. New tensions and cracks
Our health systems are on the front line.
New tensions have revealed cracks in the
structures, organizations, and strategies
discussed and the decisions taken.
Above all, Covid has tested those who are
the driving forces in the healthcare sector:
most prominently and importantly the
medical biologists at the heart of the
diagnostic testing sector.

5. Medical biology disrupted
In an era of Covid, medical biology has
moved to the foreground, no longer in
the background or behind-the-scenes of
the healthcare journey; now very much in
the public eye.
It has become exceedingly clear that it is
necessary for diagnostic testing to adapt
to a new normal that is constantly
evolving as it faces new challenges.

6. Key diagnostic
testing challenges
and opportunities

7. Challenges and
opportunities
1. Prioritizing digital solutions
2. Developing telehealth services
3. Common diagnostic records
4. Prevention and screening
5. Decentralized medical biology

8. There is an agreement and
understanding that digital
solutions can be useful in
the management of disease,
and are desired by both
patients and doctors.
01 Prioritizing Digital
Solutions

9. There is a need for
tele-health services to be
developed, supporting
healthcare professionals
with consultations,
prescriptions, and disease
management.
02 Developing
telehealth services

10. There is room to improve
the treatment approach for
patients. Patients and
healthcare professionals are
strongly in favor of
maintaining a common
diagnostic record.
03 Common
diagnostic records

11. There is an important role
for medical biology in the
field of prevention and
there is a need for direct
contact with patients to
facilitate screening and
prevention in various
disciplinary fields.
04 Prevention and
screening

12. The practice of unbundled
and decentralized
diagnostic medical biology
is underdeveloped, focused
today on emergency needs.
Second to a hospital, the
home is considered the
preferred site.
05 Decentralized
medical biology

13. A future augmented and
enabled by technology

14. Tomorrow’s Lab Today:
Focus areas for 2021
1. A more aware patient will demand a
deeper level of understanding when it
comes to their health
2. Convenience, accessibility, and quality
will form the axis of patient healthcare
3. The home will become an extension of
the hospital, clinic, and lab
4. The patient medical record will require
better interoperability and shareability
between healthcare providers

15. Medicus is a leading technology company
supporting the diagnostic industry with an
innovative digital health solution.
Medicus’ licensed, integrated, and
white-labeled B2B2C platform empowers
users to visualize and interpret health data
from blood tests and medical reports,
helping patients and users better
understand and manage their health.
Medicus works with some of the largest
providers in Europe and the Middle East,
delivering solutions and supporting specific
use cases, with a combined patient reach of
30 million and growing.
About Medicus

16. More about Medicus
Austria • Germany • France • China • UAE • Lebanon • Switzerland
● Licensed, integrated, and
white-labeled B2B2C
platform
● Founded in 2016
● Presence in 7 countries
● 100+ employees
● 30m+ patients covered by
our products today

17. Methodology
● Le Biologiste Augmenté (LBA) was undertaken to better understand the challenges and
needs of the biology community in France in partnership with Roche Diagnostics (France).
● For the 2020 edition, the second edition of the initiative, we sought to draw some parallels
between the evolution of the profession with a major crisis.
● The LBA sessions were undertaken to better understand the challenges and needs of the
medical biology and diagnostic lab community in France.
● The research included interviews with key opinion leaders in the healthcare sector in France
including the president of the union of biologists, experts in artificial intelligence, liberal and
public biologist, etc.
● We received more than 2,200 responses to an online survey, allowing us to obtain quantitative
elements on some of the questions we asked ourselves.
● For more information, or to download the full report (currently available in French), please visit
lebiologisteaugmente.com or send an email to LBA@medicus.ai

18. Dr. Baher Al Hakim, CEO
Medicus AI
baher@medicus.ai